Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Sheffield Collaboratorium for Antimicrobial Resistance and Biofilms (SCARAB),
Department of Molecular Biology and Biotechnology
Lynda Partridge has not added Biography.
If you are Lynda Partridge and would like to personalize this page please email our Author Liaison for assistance.
Direct screening for phosphatase activity by turnover-based capture of protein catalysts.
Angewandte Chemie (International ed. in English) Mar, 2002 | Pubmed ID: 12491332
High-resolution crystal structure of the Fab-fragments of a family of mouse catalytic antibodies with esterase activity.
Journal of molecular biology Sep, 2003 | Pubmed ID: 12948492
Structural requirements for the inhibitory action of the CD9 large extracellular domain in sperm/oocyte binding and fusion.
Biochemical and biophysical research communications Nov, 2003 | Pubmed ID: 14575715
Crystallization of a carbamatase catalytic antibody Fab fragment and its complex with a transition-state analogue.
Acta crystallographica. Section D, Biological crystallography Jan, 2004 | Pubmed ID: 14684920
Recombinant extracellular domains of tetraspanin proteins are potent inhibitors of the infection of macrophages by human immunodeficiency virus type 1.
Journal of virology Jul, 2006 | Pubmed ID: 16775336
The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding.
The Journal of biological chemistry Feb, 2007 | Pubmed ID: 17158873
Characterisation of receptor binding by the chemotaxis inhibitory protein of Staphylococcus aureus and the effects of the host immune response.
Molecular immunology Apr, 2007 | Pubmed ID: 17258808
Distinct roles for tetraspanins CD9, CD63 and CD81 in the formation of multinucleated giant cells.
Immunology Jun, 2009 | Pubmed ID: 19489128
Strategies for targeting tetraspanin proteins: potential therapeutic applications in microbial infections.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy , 2009 | Pubmed ID: 19894777
The role of tetraspanins in fusion.
Biochemical Society transactions Apr, 2011 | Pubmed ID: 21428932
Cooperative role for tetraspanins in adhesin-mediated attachment of bacterial species to human epithelial cells.
Infection and immunity Jun, 2011 | Pubmed ID: 21464080
Regulation of zebrafish hatching by tetraspanin cd63.
PloS one , 2011 | Pubmed ID: 21625559
Tetraspanins: gateways for infection.
Infectious disorders drug targets Feb, 2012 | Pubmed ID: 22034932
A Burkholderia pseudomallei toxin inhibits helicase activity of translation factor eIF4A.
Science (New York, N.Y.) Nov, 2011 | Pubmed ID: 22076380
Distinct regions of the large extracellular domain of tetraspanin CD9 are involved in the control of human multinucleated giant cell formation.
PloS one , 2014 | Pubmed ID: 25551757
Two complementary approaches for intracellular delivery of exogenous enzymes.
Scientific reports Jul, 2015 | Pubmed ID: 26207613
Peptides from Tetraspanin CD9 Are Potent Inhibitors of Staphylococcus Aureus Adherence to Keratinocytes.
PloS one , 2016 | Pubmed ID: 27467693
Tspan2: a tetraspanin protein involved in oligodendrogenesis and cancer metastasis.
Biochemical Society transactions 04, 2017 | Pubmed ID: 28408487
A role for the tetraspanin proteins in Salmonella infection of human macrophages.
The Journal of infection 08, 2017 | Pubmed ID: 28602860
The Use of Plant-Derived Ribosome Inactivating Proteins in Immunotoxin Development: Past, Present and Future Generations.
Toxins 10, 2017 | Pubmed ID: 29076988
Monocyte Subsets Have Distinct Patterns of Tetraspanin Expression and Different Capacities to Form Multinucleate Giant Cells.
Frontiers in immunology , 2018 | Pubmed ID: 29937768
Characterization of Ocular Clinical Isolates of from Non-Contact Lens Related Keratitis Patients from South India.
Microorganisms Feb, 2020 | Pubmed ID: 32075262
A role for tetraspanin proteins in regulating fusion induced by Burkholderia thailandensis.
Medical microbiology and immunology Apr, 2020 | Pubmed ID: 32253503
University of Sheffield
Katarzyna Okurowska1,2,
Sanhita Roy3,
Praveen Thokala4,
Lynda Partridge1,5,
Prashant Garg3,
Sheila MacNeil1,6,
Peter N. Monk1,7,
Esther Karunakaran1,2
1Sheffield Collaboratorium for Antimicrobial Resistance and Biofilms (SCARAB), University of Sheffield,
2Department of Chemical and Biological Engineering, University of Sheffield,
3Hyderabad Eye Research Foundation, L V Prasad Eye Institute,
4Health Economics and Decision Science, School of Health and Related Research, University of Sheffield,
5Department of Molecular Biology and Biotechnology, University of Sheffield,
6Department of Materials Science and Engineering, University of Sheffield,
7Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.